Education
About Us
Working with TipRanks
Follow Us
Peter Irwin Rubinstein Insider Profile
4 Followers
Peter Irwin Rubinstein, Director at Genetic Technologies, holds 3.70M shares in Genetic Technologies (Ticker: GNTLF). Most recently, Peter Irwin Rubinstein ― shares of Genetic Technologies on ― for an estimated value of ―.
Peter Irwin Rubinstein has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Peter Irwin Rubinstein's holdings
Insider Roles
Director
Roles that Peter Irwin Rubinstein holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Peter Irwin Rubinstein
Peter Irwin Rubinstein's Trading History
List of latest transactions for each holding click on a transaction to see Peter Irwin Rubinstein's performance on stock
You May Also Like
Peter Irwin Rubinstein insider profile FAQ
What is the percentage of profitable transactions made by Peter Irwin Rubinstein?
The percentage of profitable transactions made by Peter Irwin Rubinstein is ―.
What is the average return per transaction made by Peter Irwin Rubinstein?
The average return per transaction made by Peter Irwin Rubinstein is ―.
What stocks does Peter Irwin Rubinstein hold?
Peter Irwin Rubinstein holds: GNTLF stocks.
What was Peter Irwin Rubinstein’s latest transaction?
Peter Irwin Rubinstein latest transaction was an Uninformative Buy of ―.
What was Peter Irwin Rubinstein's most profitable transaction?
Peter Irwin Rubinstein’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Peter Irwin Rubinstein's role in Genetic Technologies?
Peter Irwin Rubinstein's role in Genetic Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.